RD-Biotech is a leading French company specialized since 2002 in the supply of plasmid DNA, recombinant antibodies, and associated fragments, as well as monoclonal antibodies and recombinant proteins.

As a global CRO/CDMO, RD-Biotech is a one-stop-shop partner in the supply of plasmid DNA (pDNA cloning & pDNA biomanufacturing) from R&D grade (discovery/preclinical) to « High Quality Grade » (phase 1/2 use in the production of ATMPs), as well as GMP grade (for phase 3 – commercial phase).

They support companies in the cell and gene therapy market (viral vectors, CAR-T, mRNA…)

Their main competitive advantages lie on:

– Over 20 years of experience in molecular biology, engineering & biomanufacturing

– Complete offer from early discovery (pDNA cloning) to commercial manufacturing (GMP grade)

– Scalable process of pDNA production, from several mg up to 20 g, for R&D, High Quality and GMP grades

– Cost effective & adaptable process

–  Therapeutic areas: Cell and Gene therapies: DNA vaccines, RNA vaccines, CAR-T cells, viral based therapies…

–  Based in: Besançon (FRANCE)

–  Employees: 11 – 50

– Created in: 2002